Serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in Wilson's disease

Background In Wilson's disease (WD), early neurological deterioration after treatment initiation is associated with poor outcomes; however, data on this phenomenon are limited. Our study analysed the frequency and risk factors of early neurological deterioration in WD. Methods Early neurological deterioration, within 6 months from diagnosis, was defined based on the Unified Wilson's Disease Rating Scale (UWDRS): any increase in part II or an increase of >= 4 in part III. In total, 61 newly diagnosed WD patients were included. UWDRS scores, brain magnetic resonance imaging (MRI) scores, copper metabolism parameters, treatment type and serum neuro-filament light chain (sNfL) concentrations at diagnosis were analysed as potential risk factors of early deterioration. Results Early neurological deterioration was observed in 16.3% of all WD patients; all cases of worsening occurred in the neurological phenotype (27.7%). Higher scores were seen in those who deteriorated compared with those who did not for UWDRS part II (4.3 +/- 5.0 vs 2.0 +/- 5.9; p < 0.05), UWDRS part III (21.5 +/- 14.1 vs 9.3 +/- 16.4; p < 0.01) and MRI-assessed chronic damage (3.2 +/- 1.6 vs 1.4 +/- 2.2; p = 0.006); all these variables indicated the initial severity of neurological disease. Pre-treatment sNfL concentrations were significantly higher in patients who deteriorated compared with those who did not (33.2 +/- 23.5 vs 27.6 +/- 62.7 pg/mL; p < 0.01). In univariate logistic regression amongst all patients, chronic damage MRI scores, UWDRS part III scores and sNfL concentrations predicated early deterioration. In the neurological WD, only sNFL were a significant predictor. In bivariate logistic regression amongst all patients, sNfL remained the only significant predictor of deterioration when corrected for MRI scores. Conclusion sNfL concentrations are a promising biomarker of the risk of early neurological deterioration in WD.

Automated summary

This study analyzed the frequency and risk factors of early neurological deterioration in Wilson's disease (WD). The results showed that early deterioration is common in WD patients, particularly in the neurological phenotype. The severity of initial neurological disease and pre-treatment serum neuro-filament light chain (sNfL) concentrations were identified as significant risk factors.